Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening

Nowadays identification of novel non-peptide β-secretase (BACE-1, hereinafter) inhibitors with low cytotoxicity and good blood–brain barrier (BBB) property holds common interest of drug discovery for Alzheimer’s disease. Twenty SPECS compounds were tested in BACE-1 FRET assays and methylthiazoletetr...

Full description

Bibliographic Details
Main Authors: Xu, W., Chen, G., Zhu, W., Zuo, Zhili
Format: Journal Article
Published: Pergamon 2010
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/9340
_version_ 1848745921116897280
author Xu, W.
Chen, G.
Zhu, W.
Zuo, Zhili
author_facet Xu, W.
Chen, G.
Zhu, W.
Zuo, Zhili
author_sort Xu, W.
building Curtin Institutional Repository
collection Online Access
description Nowadays identification of novel non-peptide β-secretase (BACE-1, hereinafter) inhibitors with low cytotoxicity and good blood–brain barrier (BBB) property holds common interest of drug discovery for Alzheimer’s disease. Twenty SPECS compounds were tested in BACE-1 FRET assays and methylthiazoletetrazolium (MTT) cytotoxicity experiment. Two compounds: 2 and 15 demonstrated IC50 values of 0.53 and 9.4 μM. In addition, 2 showed least toxic effect to the neuroblastoma cells. The results from both in silico and in vitro studies provided new pharmacophoric entities for chemical synthesis and optimization on the current discovered BACE-1 small molecule inhibitors.
first_indexed 2025-11-14T06:25:02Z
format Journal Article
id curtin-20.500.11937-9340
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:25:02Z
publishDate 2010
publisher Pergamon
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-93402019-02-19T04:27:47Z Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening Xu, W. Chen, G. Zhu, W. Zuo, Zhili FRET Virtual screening Bioassay BACE-1 Nowadays identification of novel non-peptide β-secretase (BACE-1, hereinafter) inhibitors with low cytotoxicity and good blood–brain barrier (BBB) property holds common interest of drug discovery for Alzheimer’s disease. Twenty SPECS compounds were tested in BACE-1 FRET assays and methylthiazoletetrazolium (MTT) cytotoxicity experiment. Two compounds: 2 and 15 demonstrated IC50 values of 0.53 and 9.4 μM. In addition, 2 showed least toxic effect to the neuroblastoma cells. The results from both in silico and in vitro studies provided new pharmacophoric entities for chemical synthesis and optimization on the current discovered BACE-1 small molecule inhibitors. 2010 Journal Article http://hdl.handle.net/20.500.11937/9340 10.1016/j.bmcl.2010.07.140 Pergamon fulltext
spellingShingle FRET
Virtual screening
Bioassay
BACE-1
Xu, W.
Chen, G.
Zhu, W.
Zuo, Zhili
Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
title Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
title_full Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
title_fullStr Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
title_full_unstemmed Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
title_short Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
title_sort identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
topic FRET
Virtual screening
Bioassay
BACE-1
url http://hdl.handle.net/20.500.11937/9340